NETWORKING RECEPTION - POSTERS, EXHIBITS AND HUBTALKS
HT-12 - THE OBESITY DRUG REVOLUTION: WHY CARDIOLOGISTS CAN'T AFFORD TO IGNORE IT
Friday, October 24, 2025
5:30pm - 5:50pm ET
Room: Theatre 3
Sponsored By
This Hub Talk will provide delegates with an engaging and evidence-based update on the new Obesity Canada pharmacotherapy guideline recommendations. Obesity care has rapidly evolved with the emergence of novel obesity medications and expanded evidence supporting their efficacy, safety, and role in long-term management.
Learning Objectives:
At the end of this session participants will be able to:
understand the latest updates in the Canadian Adult Obesity Pharmacotherapy Clinical Practice Guideline, including new therapeutic agents and evidence on clinical outcomes;
apply guideline recommendations to case scenarios, supporting patient-centered care and shared decision-making; and
evaluate how advances in pharmacotherapy can be integrated into comprehensive obesity management strategies alongside lifestyle and surgical interventions.
